Skip to main content
Midas Edge

Acumen Pharmaceuticals Inc

For the period ended Jun 4, 2024. Filed Apr 22, 2024.

View on SEC.gov

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

Jun 4, 2024 · Filed Apr 22, 2024

ABOS$0.22+4.5%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits
Contents

Code Of Ethics

The Company has adopted the Acumen Code of Business Conduct and Ethics, which applies to all officers, directors and employees. The Code of Business Conduct and Ethics is available on the Company’s website atwww.acumenpharm.com. If the Company makes any substantive amendments to the Code of Business Conduct and Ethics or grants any waiver from a provision of the Code of Business Conduct and Ethics to any executive officer or director, the Company will promptly disclose the nature of the amendment or waiver on its website.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.